Key facts
- China has approved the first novel therapy developed with the assistance of artificial intelligence.
- This marks a significant milestone in AI-driven drug discovery globally.
- The therapy is designed to treat specific types of cancer.
China has achieved a global first by approving a novel therapy that was developed using artificial intelligence. This landmark decision positions Beijing ahead of other nations in the application of AI for drug discovery and development. The therapy is specifically designed to target and treat certain types of cancer, signaling a new era in pharmaceutical innovation driven by advanced technology.